Oncology Institute (DFPH) Depreciation & Amortization (CF) (2021 - 2026)

Oncology Institute (DFPH) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $1.6 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 9.42% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (up 2.95% YoY) and the FY2025 annual result came in at $6.9 million, up 10.45% from the prior year.
• Depreciation & Amortization (CF) slipped to $1.6 million in Q1 2026, from $1.6 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.8 million in Q2 2025 to a low of $987000.0 in Q1 2022.
• A 5-year average of $1.5 million and a median of $1.6 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) soared 49.74% — and 2026, when it fell 9.42%.
• Tracing DFPH's Depreciation & Amortization (CF) over 5 years: stood at $1.2 million in 2022, then jumped by 32.3% to $1.6 million in 2023, then grew by 8.24% to $1.7 million in 2024, then declined by 4.39% to $1.6 million in 2025, then fell by 0.98% to $1.6 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.